$9.75
Price
$1.6B
Market Cap
4.9
P/E Ratio
-26.9
Forward P/E
$2.01
EPS (TTM)
—
Dividend Yield
$763M
Cash
$230M
Total Debt
162M
Shares Out
$5.01
$10.64
52-Week Range
Institutional Ownership of NOVAVAX INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NOVAVAX INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for NOVAVAX INC
6 Months Insider Sentiment
Buy $0
Sell $0
0
Buys
0
Sells
+0
Net
0
Grants
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Mark J Casey | EVP, Chief Legal Officer | EXERCISE | 41.9K | — | — |
| Nov 11, 2025 | Ruxandra Draghia-Akli | Section 16 | EXERCISE | 14.3K | — | — |
| Oct 29, 2025 | Richard J Rodgers | Director | EXERCISE | 3.8K | — | — |